Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NRIX
#1905
Nurix Therapeutics, Inc. Common stock
15.970
0
+2.70%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+2.70%
Monthly Change
-18.42%
6 month change
+42.46%
Cambio anual
+42.46%
Cierres anteriores
15.550
0
Open
15.970
0
Bid
Ask
Low
15.970
0
High
15.970
0
Volumen
162
Markets
Acciones
Atención Sanitaria
NRIX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
38.91 M
44.74 M
47.27 M
48.89 M
75.89 M
102.84 M
—
Valuation ratios
Enterprise value
1.54 B
1.21 B
521.24 M
249.49 M
1.52 B
1.49 B
4.06 B
Price to earnings ratio
—
—
-3.34
-2.35
-7.46
-5.54
-18.83
Price to sales ratio
—
—
15.59
4.39
26.44
17.45
56.77
Price to cash flow ratio
—
—
3.77
4.15
8.36
5.87
19.16
Price to book ratio
—
—
1.98
1.69
2.74
2.72
4.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.25
0.43
0.4
0.29
0.38
0.44
Return on equity %
0.15
0.34
0.59
0.72
0.37
0.49
0.59
Return on invested capital %
132.86
270.56
403.07
629.36
713.83
923.04
904.34
Gross margin %
100
100
100
100
100
100
400
Operating margin %
364.66
396.26
476.01
201.41
390.52
340.16
2 220.03
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
242.66
393.93
466.93
186.98
354.85
314.9
2 074.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.7
4.7
4.51
3.4
6.46
7.02
25.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.04
0.07
0.09
0.2
0.11
0.12
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
3.29
1.5
2.57
2.88
2.95
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
6.36
5.3
9.08
6.84
24.31
Net current asset value per share
—
—
6.55
5.44
9.23
7
25.13
Tangible book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Working capital per share
—
—
5.1
3.84
7.8
6
21.17
Book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Noticias
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Christine Ring, directora jurídica de Nurix, vende acciones de NRIX por 237.000 dólares
Directora legal de Nurix vende acciones NRIX por $237k
CFO de Nurix Therapeutics vende acciones por $61,000
Directora legal de Nurix Therapeutics vende acciones por $73,000
Nurix Therapeutics CFO Hans van Houte sells $61k in shares
Nurix Therapeutics chief legal officer Ring sells $73k in stock
La directora científica de Nurix Therapeutics, Gwenn Hansen, vende acciones por 81.000 dólares
Directora científica de Nurix Therapeutics vende acciones por $81,000
Nurix Therapeutics CSO Gwenn Hansen sells $81k in shares
Stifel eleva precio objetivo de Nurix a $35 por potencial de bexobrutideg
Stifel eleva el precio objetivo de Nurix a 35 dólares por el potencial de bexobrutideg